Vincerx Pharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Vincerx Pharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2019 to Q3 2024.
  • Vincerx Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 31.4M shares, a 46.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 31.4M +10M +46.8% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 29.7M +8.29M +38.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 21.4M +168K +0.79% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 21.4M +165K +0.78% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 21.4M +191K +0.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 21.4M +191K +0.9% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 21.2M +188K +0.89% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 21.2M +185K +0.88% Dec 31, 2022 10-K 2024-03-29
Q3 2022 21.2M +169K +0.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 21.2M +3.67M +20.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 21.1M +6.36M +43.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 21.1M +7.07M +50.6% Dec 31, 2021 10-K 2023-03-28
Q3 2021 21M +18.6M +761% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 17.5M +15.1M +631% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 14.7M +12.3M +516% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 14M +8.79M +169% Dec 31, 2020 10-K 2022-03-29
Q3 2020 2.44M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 2.4M +960K +66.8% Jun 30, 2020 10-Q 2020-11-10
Q1 2020 2.39M Mar 31, 2020 10-Q 2020-05-06
Q4 2019 5.2M Dec 31, 2019 10-K/A 2021-05-14
Q2 2019 1.44M Jun 30, 2019 10-K 2020-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.